Article

Asymmetrical Loading Appears Early in Osteoarthritis

In patients with unilateral hip osteoarthritis (OA)-where the risk of progressive symptomatic OA developing in contralateral knees is higher than in ipsilateral knees-loading and structural asymmetries appear early in the disease course, while the knees are still asymptomatic.

In patients with unilateral hip osteoarthritis (OA)-where the risk of progressive symptomatic OA developing in contralateral knees is higher than in ipsilateral knees-loading and structural asymmetries appear early in the disease course, while the knees are still asymptomatic. These early asymmetries may have corresponding long-term consequences, providing further evidence for the potential role of loading in OA onset and progression.

Shakoor and coworkers evaluated data on 62 patients with unilateral hip OA. All patients underwent pelvis and knee radiography; were assessed for pain in both knees and both hips; and underwent gait analysis, which included collection of 3-dimensional kinematic and ground reaction force data. Dual x-ray absorptiometry was used for bone mineral density (BMD) analysis. Differences between the knees were noted.

Peak dynamic knee loads were significantly higher at the contralateral knee than at the ipsilateral knee, and medial compartment tibial BMD was significantly higher in the contralateral knee. The ratio of contralateral:ipsilateral medial compartment knee BMD was directly correlated with contralateral:ipsilateral peak external knee adduction moment and contralateral:ipsilateral knee medial compartment load.

The authors noted that their findings provide support for the notion that alterations in dynamic joint loading may precede the onset of symptomatic knee OA.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.